Skip to content

Elamipretide (SS-31) studies: 372 papers with results

Page 3 of 8

  1. Mitochondria-Related Ferroptosis Drives Cognitive Deficits in Neonatal Mice Following Sevoflurane Administration.

    Zhang P · Frontiers in medicine · 2022

    Animal study (in vivo) · mouse · 1 result

  2. Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization.

    Zhang H · Journal of neuroinflammation · 2023

    Animal study (in vivo) · mouse · 4 results

  3. Mitochondrial oxidative stress induces leaky ryanodine receptor during mechanical ventilation.

    Dridi H · Free radical biology & medicine · 2020

    Animal study (in vivo) · mouse · 6 results

  4. Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice.

    Yang SK · Oxidative medicine and cellular longevity · 2019

    Animal study (in vivo) · mouse · 19 results

  5. Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice.

    Lu HI · Acta pharmacologica Sinica · 2016

    Animal study (in vivo) · mouse · 20 results

  6. Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice.

    Zuo Y · Frontiers in cellular neuroscience · 2020

    Animal study (in vivo) · mouse · 3 results

  7. SS-31 peptide enables mitochondrial targeting drug delivery: a promising therapeutic alteration to prevent hair cell damage from aminoglycosides.

    Kuang X · Drug delivery · 2017

    Animal study (in vivo) · zebrafish · 6 results

  8. Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats.

    Wu J · Frontiers in cellular neuroscience · 2017

    Animal study (in vivo) · rat · 3 results

  9. Novel mitochondria-targeted antioxidant peptide ameliorates burn-induced apoptosis and endoplasmic reticulum stress in the skeletal muscle of mice.

    Lee HY · Shock (Augusta, Ga.) · 2011

    Animal study (in vivo) · mouse · 6 results

  10. Protective effects of mitochondrion-targeted peptide SS-31 against hind limb ischemia-reperfusion injury.

    Cai J · Journal of physiology and biochemistry · 2018

    Animal study (in vivo) · mouse · 11 results

  11. Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model.

    Wu X · Acta biochimica et biophysica Sinica · 2019

    Animal study (in vivo) · rat · 11 results

  12. SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease.

    Yang Q · Frontiers in pharmacology · 2021

    Animal study (in vivo) · 2 results

  13. Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice.

    Bhatti JS · Molecular neurobiology · 2021

    Animal study (in vivo) · mouse · 2 results

  14. Mitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.

    Ryan TE · Journal of molecular and cellular cardiology · 2016

    Animal study (in vivo) · mouse · 6 results

  15. Mitochondria-targeted antioxidant peptide SS31 protects the retinas of diabetic rats.

    Huang J · Current molecular medicine · 2013

    Animal study (in vivo) · rat · 14 results

  16. Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness.

    Smuder AJ · Oncotarget · 2020

    Animal study (in vivo) · mouse · 6 results

  17. The Mitochondria-targeted Peptide, Bendavia, Attenuated Ischemia/Reperfusion-induced Stroke Damage.

    Imai T · Neuroscience · 2020

    Animal study (in vivo) · mouse · 7 results

  18. Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants.

    Daneshgar N · Communications biology · 2021

    Animal study (in vivo) · mouse · 1 result

  19. Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway.

    Zhang L · International journal of molecular medicine · 2021

    Animal study (in vivo) · mouse · 8 results

  20. SS-31 inhibits mtDNA-cGAS-STING signaling to improve POCD by activating mitophagy in aged mice.

    Ji Y · Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024

    Animal study (in vivo) · mouse · 6 results

  21. Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins.

    Whitson JA · GeroScience · 2021

    Animal study (in vivo) · mouse · 3 results

  22. A mitochondrial-targeted peptide ameliorated podocyte apoptosis through a HOCl-alb-enhanced and mitochondria-dependent signalling pathway in diabetic rats and in vitro.

    Wang X · Journal of enzyme inhibition and medicinal chemistry · 2019

    Animal study (in vivo) · rat · 9 results

  23. Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet.

    Zhang M · PloS one · 2017

    Animal study (in vivo) · mouse · 11 results

  24. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.

    Russo S · Scientific reports · 2022

    Animal study (in vivo) · mouse · 3 results

  25. Mitochondrial-Targeting Antioxidant SS-31 Suppresses Airway Inflammation and Oxidative Stress Induced by Cigarette Smoke.

    Yang DQ · Oxidative medicine and cellular longevity · 2021

    Animal study (in vivo) · mouse · 23 results

  26. Mitochondria Targeted Peptide Attenuates Mitochondrial Dysfunction, Controls Inflammation and Protects Against Spinal Cord Injury-Induced Lung Injury.

    Zhu LL · Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2017

    Animal study (in vivo) · mouse · 9 results

  27. Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P nuclear magnetic resonance and electron paramagnetic resonance spectroscopy.

    Righi V · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2013

    Animal study (in vivo) · mouse · 3 results

  28. Brown adipose tissue and its modulation by a mitochondria-targeted peptide in rat burn injury-induced hypermetabolism.

    Yo K · American journal of physiology. Endocrinology and metabolism · 2013

    Animal study (in vivo) · rat · 2 results

  29. Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages.

    Nie Y · Antioxidants (Basel, Switzerland) · 2023

    Animal study (in vivo) · mouse · 14 results

  30. Contradictory effects of mitochondria- and non-mitochondria-targeted antioxidants on hepatocarcinogenesis by altering DNA repair in mice.

    Wang B · Hepatology (Baltimore, Md.) · 2018

    Animal study (in vivo) · mouse · 6 results

  31. Protective Effects of Antioxidant Peptide SS-31 Against Multiple Organ Dysfunctions During Endotoxemia.

    Li G · Inflammation · 2016

    Animal study (in vivo) · 12 results

  32. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.

    Russo S · Scientific reports · 2024

    Animal study (in vivo) · mouse · 2 results

  33. A Water-Soluble Quercetin Conjugate with Triple Targeting Exerts Neuron-Protective Effect on Cerebral Ischemia by Mitophagy Activation.

    Cen J · Advanced healthcare materials · 2022

    Animal study (in vivo) · 4 results

  34. Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ mice.

    Bhatti JS · Mitochondrion · 2021

    Animal study (in vivo) · mouse · 2 results

  35. Hypertension Exacerbates Cerebrovascular Oxidative Stress Induced by Mild Traumatic Brain Injury: Protective Effects of the Mitochondria-Targeted Antioxidative Peptide SS-31.

    Czigler A · Journal of neurotrauma · 2019

    Animal study (in vivo) · rat · 3 results

  36. SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice.

    Jia YL · Current Alzheimer research · 2016

    Animal study (in vivo) · mouse · 6 results

  37. Reduced adenosine diphosphate sensitivity in skeletal muscle mitochondria increases reactive oxygen species production in mouse models of aging and oxidative stress but not denervation.

    Pharaoh G · JCSM rapid communications · 2021

    Animal study (in vivo) · mouse · 4 results

  38. SS31 attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage possibly by the mitochondrial pathway.

    Shen R · Neuroscience letters · 2020

    Animal study (in vivo) · rat · 9 results

  39. The Mitochondria-Targeted Peptide Therapeutic Elamipretide Improves Cardiac and Skeletal Muscle Function During Aging Without Detectable Changes in Tissue Epigenetic or Transcriptomic Age.

    Mitchell W · Aging cell · 2025

    Animal study (in vivo) · mouse (c57bl and 6j) · 9 results

  40. SS-31 as a Mitochondrial Protectant in the Treatment of Tendinopathy: Evaluation in a Murine Supraspinatus Tendinopathy Model.

    Zhang X · The Journal of bone and joint surgery. American volume · 2022

    Animal study (in vivo) · mouse · 6 results

  41. Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats.

    Liu Y · Frontiers in aging neuroscience · 2021

    Animal study (in vivo) · rat · 4 results

  42. SS-31 Improves Cognitive Function in Sepsis-Associated Encephalopathy by Inhibiting the Drp1-NLRP3 Inflammasome Activation.

    Zhong L · Neuromolecular medicine · 2023

    Animal study (in vivo) · mouse · 11 results

  43. Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.

    Swain L · Circulation · 2024

    Animal study (in vivo) · pig · 5 results

  44. SS31 Alleviates Pressure Overload-Induced Heart Failure Caused by Sirt3-Mediated Mitochondrial Fusion.

    Suo M · Frontiers in cardiovascular medicine · 2022

    Animal study (in vivo) · mouse · 7 results

  45. SS-31 alleviated nociceptive responses and restored mitochondrial function in a headache mouse model via Sirt3/Pgc-1α positive feedback loop.

    Shan Z · The journal of headache and pain · 2023

    Animal study (in vivo) · mouse · 3 results

  46. Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury.

    Jiang W · CNS neuroscience & therapeutics · 2023

    Animal study (in vivo) · 7 results

  47. Evaluation of the antioxidant peptide SS31 for treatment of burn-induced insulin resistance.

    Carter EA · International journal of molecular medicine · 2011

    Animal study (in vivo) · mouse · 3 results

  48. Mitochondria-targeting peptide SS-31 attenuates ferroptosis via inhibition of the p38 MAPK signaling pathway in the hippocampus of epileptic rats.

    Liu X · Brain research · 2024

    Animal study (in vivo) · rat (wistar) · 7 results

  49. SS31, a mitochondrially targeted antioxidant, prevents sepsis-induced reductions in diaphragm strength and endurance.

    Supinski GS · Journal of applied physiology (Bethesda, Md. : 1985) · 2020

    Animal study (in vivo) · mouse · 9 results

  50. Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria.

    Kingren MS · Molecular medicine (Cambridge, Mass.) · 2024

    Animal study (in vivo) · mouse · 1 result

How PepBank reports evidence